Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-29

Clinical Trial Update: The Prevent Coronary Artery Disease Trial [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 study assessing prevention of atherosclerotic cardiovascular disease. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Atherosclerotic Cardiovascular Disease | Phase 3 | Status: RECRUITING